Bioengineer.org Subject of Research: Ozone therapy as an investigational adjunct in colorectal cancer Article Title: Ozone therapy in colorectal cancer News Source: Nathaniel Bowman. (November 4, 2026). Ozone Therapy for Colorectal Cancer Remains an Unproven Idea, Review Finds. Scienmag.
Nov 4, 2026 | Cancer, Molecular Diagnostics | A study of nearly 12,000 patients found that a nonendoscopic device used to collect samples for esophageal precancer testing achieved a 95% collection success rate, with procedures taking less than two minutes on average. The study, published in…
A new review in Cell Division details how colorectal cancer cells form their own blood-supply channels through vasculogenic mimicry, a process linked to poorer prognosis and resistance to antiangiogenic drugs. News Source: Nathaniel Bowman. (November 4, 2026). Tumor Cells Build Their Own…
Nature Medicine (2026) Cite this article The incidence of early-onset colorectal cancer is rising, but whether it is biologically distinct from average-onset disease is unclear. Mapping of the transcriptome of colorectal tumors across the age continuum shows that tumors in younger…
EurekAlert! A/Prof Zhang Yongliang and Dr Li Heng, both from the Department of Microbiology and Immunology, NUS Medicine. The immune system has powerful cells that can recognise and destroy cancer, but this ability can gradually wane when the cells…
Figure 2. Dermoscopy image of the pink nodule from Figure 1. Did you know you can now log your CPD with a click of a button? Australian Journal of General Practice (AJGP) is published by The Royal Australian College of General Practitioners,…
Yet the story is not one-sided. The review gathers multiple lines of evidence indicating that excessive spermidine, or altered flux through the polyamine pathway, can be cytotoxic. Several reports demonstrate that high-dose spermidine triggers apoptosis, the process of programmed cell…
Dr. Jay Lalezari of CytoDyn recently reported that the circulating tumor DNA results observed in colorectal cancer patients treated with Leronlimab provide a mechanism-specific proof of concept for the drug. The findings suggest that the clinical data serves as a…
The multicenter study evaluated botensilimab, an Fc-enhanced anti-CTLA-4 antibody developed by Agenus, alone or combined with balstilimab, an anti-PD-1 antibody, in patients with locally advanced, resectable colon cancer. Among patients with pMMR/MSS tumors receiving the combination, 36% achieved a major…
In a Scandinavian clinical trial in Norway, Sweden and Denmark, aspirin did not reduce the risk of colorectal cancer returning in patients after treatment for liver metastases. As News-Medical reports, the ASAC trial was coordinated by Oslo University Hospital. The…
Testicular checks, skin exams, colon and prostate risk discussions and timing.
An article joins this feed when it matches these terms. Each one is also a search of its own.